Autres langues Xencor, Inc.

Actions

Temps réel estimé Cboe BZX Autres places de cotation 20:10:11 07/06/2024			Varia. 5j.	Varia. 1 janv.
21,82 ^USD	-0,43 %		-7,53 %	+3,49 %

15/05	Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM
10/05	XENCOR, INC. : Wedbush à l'achat	ZM

The Appeals Review Panel's In Re Xencor Decision: The USPTO Provides Its Position On Written Description And Means-Plus-Function Claims	24/05
Xencor: Q1 Earnings Snapshot	09/05
Earnings Flash (XNCR) XENCOR Reports Q1 Revenue $12.8M	09/05
Xencor Reports First Quarter 2024 Financial Results	09/05
Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Xencor Names Bart Cornelissen as Chief Financial Officer	09/04
Xencor Appoints Bart Cornelissen as Chief Financial Officer	09/04
Xencor, Inc. Announces CFO Changes	09/04
Xencor Appoints Bart Cornelissen as Senior Vice President	09/04
USTPO Issues Means-Plus-Function Memorandum	27/03
Xencor Insider Sold Shares Worth $293,519, According to a Recent SEC Filing	07/03
North American Morning Briefing : Fed's Preferred -2-	29/02
Xencor to Present at Upcoming Investor Conferences	28/02
Xencor: Q4 Earnings Snapshot	27/02
Earnings Flash (XNCR) XENCOR Posts Q4 Revenue $44.7M, vs. Street Est of $74.7M	27/02
Xencor, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/02
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results	27/02
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update	20/02
Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi	19/02
Xencor Insider Sold Shares Worth $1,048,743, According to a Recent SEC Filing	14/02

Aucun résultat pour cette recherche